Detailed Information

Cited 61 time in webofscience Cited 68 time in scopus
Metadata Downloads

Sleeve Lobectomy as an Alternative Procedure to Pneumonectomy for Non-small Cell Lung Cancer

Authors
Park, JS[Park, Joon Suk]Yang, HC[Yang, Hee Chul]Kim, HK[Kim, Hong Kwan]Kim, K[Kim, Kwhanmien]Shim, YM[Shim, Young Mog]Choi, YS[Choi, Yong Soo]Kim, J[Kim, Jhingook]
Issue Date
Apr-2010
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
Non-small cell lung cancer; Sleeve lobectomy; Pneumonectomy
Citation
JOURNAL OF THORACIC ONCOLOGY, v.5, no.4, pp.517 - 520
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF THORACIC ONCOLOGY
Volume
5
Number
4
Start Page
517
End Page
520
URI
https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/74553
DOI
10.1097/JTO.0b013e3181d0a44b
ISSN
1556-0864
Abstract
Introduction: The aim of this study is to compare the outcomes of sleeve lobectomy (SL) and pneumonectomy (PN) and to determine which one is more acceptable standard procedure for patients with non-small cell lung cancer. Methods: From 1996 to 2005, 424 patients underwent SL (n = 157) and PN (n = 267) in our institution. Propensity score matching analysis was performed to compare these two groups for mortality, morbidity, survival, recurrence, and postoperative pulmonary function. Results: In each group, 105 patients were eligible for analysis. The operative mortality was lower in the SL group (1.0%) than the PN group (8.6%), (p < 0.0001). The morbidity was similar (33.4% versus 29.5%, p = 0.376). The 5-year survival was lower in the PN group (PN, 32.14% versus SL, 58.43%, p = 0.0002). The recurrence pattern (locoregional versus distant) did not differ between two groups (p = 0.180). The mean actual postoperative first second forced expiratory volume in the patients underwent SL was 2.05 +/- 0.55 liter, which increased by 7.9% compared with the predicted-postoperative first second forced expiratory volume. Conclusions: Our results showed that the SL can be performed with low operative risk and may offer superior survival and better postoperative pulmonary function compared with the PN in selected patients. If anatomically feasible, a SL must be considered as a favorable alternative to PN in patients with non-small cell lung cancer.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Medicine > Department of Medicine > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher KIM, HONG KWAN photo

KIM, HONG KWAN
Medicine (Medicine)
Read more

Altmetrics

Total Views & Downloads

BROWSE